Micromet, Inc. · Bethesda, MD United States (NASDAQ: MITI)
| 6707 Democracy Blvd., Ste. 505 | Phone: 240-752-1420 |
| Bethesda, MD | Fax: 240-752-1425 |
| 20817 | |
| United States | 
Map This Company |
Micromet, Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
Micromet likes to bring along a big buddy along when it's looking to fight disease. The drug development firm is developing a pipeline of cancer treatments using its BiTE technology, which harnesses the body's own T cells to attack disease. Some of its lead candidates include MT103 which is being studied to treat leukemia and MT110 for the treatment of solid tumors. It is also developing a number of treatments in collaboration with other pharmaceutical companies including one for arthritis with
Micromet, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: MITI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 192 |
Executives
17 executives listed for Micromet, Inc.'s Bethesda, MD location.
| Chairman | David Hale | |
|---|---|---|
| President, CEO, and Director | Christian Itin | |
| SVP and CFO | Barclay Phillips |